BioSpace News Archive

Biotech Bay

Arcellx Announces Clinical Hold for its iMMagine-1 Phase 2 Clinical Program

Arcellx, Inc. (NASDAQ: ACLX) announced today that it has received notification from the U.S. Food and Drug Administration (FDA) that a clinical hold has been placed on its CART-ddBCMA investigational new drug (IND) for the treatment of patients with relapsed or refractory multiple myeloma (rrMM).

June 19, 2023
·
6 min read
Drug Development

Sensorion Reports Promising Preliminary Data from SENS-401 Phase 2a Clinical Study

Sensorion announces promising preliminary results from its Proof of Concept Phase 2a clinical trial of SENS-401 for residual hearing preservation following cochlear implantation.

June 19, 2023
·
7 min read
Drug Development

Allgenesis Announces Encouraging Phase 1b Data Showing AG-80308 Providing Improvements in Multiple Signs and Symptoms in Dry Eye Patients

Allgenesis Biotherapeutics Inc. announced topline data from the company’s Phase 1b clinical trial for AG-80308, a first-in-class, formyl peptide receptor agonist formulated as an aqueous solution eye drop for the treatment of Dry Eye Disease.

June 19, 2023
·
2 min read
Business

Gene Bio Medical Announces Significant Partnership with HI³ as part of the PREPARED Project

Gene Biotechnology Enterprises Ltd., also known as Gene Bio Medical, is excited to announce its strategic partnership with the Canadian Hub for Health Intelligence & Innovation in Infectious Diseases.

June 19, 2023
·
3 min read
Bergen Prepares to Host International Conference on Hansen’s Disease Marking 150 Years Since the Discovery of the Leprosy Bacillus

The Sasakawa Leprosy (Hansen’s Disease) Initiative and the University of Bergen are organizing a two-day conference in Bergen, Norway, on June 21-22, 2023, to commemorate the 150 th anniversary of the discovery of M. leprae , the causative agent of leprosy, in 1873.

June 19, 2023
·
4 min read
Lone Star Bio

Orthofix Announces the Full Commercial Launch of WaveForm A 3D Printed Anterior Lumbar Interbody

Orthofix Medical Inc . (NASDAQ:OFIX), a leading global spine and orthopedics company, today announced the full commercial launch of the WaveForm ® A interbody for Anterior Lumbar Interbody Fusion (ALIF) procedures.

June 19, 2023
·
6 min read
CORRECTION FROM SOURCE: NLS Pharmaceutics to Participate in the Healthcare Virtual Conference Presented by Maxim Group LLC and Hosted by M-Vest

NLS Pharmaceutics Ltd. today announced that Alex Zwyer, Chief Executive Officer of NLS Pharmaceutics will present at the Healthcare Virtual Conference Part II, presented by Maxim Group LLC and hosted by M-Vest on Tuesday, June 20, 2023, at 10:30 AM ET.

June 19, 2023
·
1 min read
SK bioscience COVID-19 Vaccine Granted Emergency Use Listing by the World Health Organization

SK bioscience announced the company has received the WHO Emergency Use Listing (EUL) of its COVID-19 vaccine, SKYCovione.

June 19, 2023
·
2 min read
Business

Innovaderm appoints Cedric Burg as new Chief Operating Officer

Innovaderm welcomes Cedric Burg as its new Chief Operating Officer. Mr. Burg’s new role entails the management of Innovaderm’s global operations in Canada, through the close collaboration between department heads while overseeing most of Innovaderm’s activities.

June 19, 2023
·
1 min read
Biotech Bay

Advancements in Multiomics: Automation of RNAscopeTM on NanoVIP® Saves 50% Reagent Cost and 65% Hands-on Time in Spatial Biology Research

Omicsveu is committed to advance the pace of Spatial Biology research through yet another achievement, automating RNAscopeTM manual protocol with NanoVIP® All-in-One autostainer.

June 19, 2023
·
1 min read